Phar­ma com­pa­nies still slow to adopt hy­brid sales rep and dig­i­tal com­mer­cial mod­els – sur­vey

Af­ter the pan­dem­ic spurred a rush to dig­i­tal com­mer­cial­iza­tion strate­gies, phar­ma com­pa­nies re­al­ized they need­ed to evolve their tra­di­tion­al sales rep-led mod­els. How­ev­er, they’re still …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER